Akeso have supported Tanner Pharma Group UK’s successful delivery of over 300m units of lateral flow devices (LFDs) to the UKHSA from October 2021 to May 2022.
TPGUK were contracted by the UKHSA in October 2021 to supply LFDs through an intricate and complex global supply chain.
Combined with the emergence of the Omicron variant and in the lead up winter 2021, the project rapidly escalated in scale and scope.
Akeso, as supply chain and procurement experts, were contracted to support and oversee all elements of the logistics and delivery process.
Our priority was to understand manufacturing capacity which would ultimately dictate the delivery schedule. We had numerous meetings with manufacturing partners in China to review their production capacity and plan the downstream deliveries accordingly. Additionally, we developed a flight tracker to balance flights booked against the production capacity. In this way, we ensured that cost effective utilisation of flights while also maximising the capacity to inbound LFDs into the U.K. at a time of increased demand.
Initial support regarding logistics tracking and planning progressed to overall management and integration with flight planning elements. We led stakeholder engagement and management through the daily operations review calls schedule with Kuehne and Nagel (TPGUK’s logistics sub-contractor) and twice weekly contract progress report updates to UKHSA.
Akeso supported the delivery of over 300m LFDs to the UKHSA. This involved over 150 flights via 27 different routes involving 13 Chinese and 10 U.K airports over four months. With logistic and planning improvements, we delivered a relative reduction of 28% in flight costs, a 33% damage rate reduction and a 40% relative reduction in storage charges.